KR970701532A - 피부 주름을 조절하기 위한 환상 다가음이온 폴리올 유도체의 사용 방법(methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles) - Google Patents

피부 주름을 조절하기 위한 환상 다가음이온 폴리올 유도체의 사용 방법(methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles)

Info

Publication number
KR970701532A
KR970701532A KR1019960704857A KR19960704857A KR970701532A KR 970701532 A KR970701532 A KR 970701532A KR 1019960704857 A KR1019960704857 A KR 1019960704857A KR 19960704857 A KR19960704857 A KR 19960704857A KR 970701532 A KR970701532 A KR 970701532A
Authority
KR
South Korea
Prior art keywords
composition
skin
hoch
opo
effective amount
Prior art date
Application number
KR1019960704857A
Other languages
English (en)
Inventor
제랄드 브루스 캐스팅
죤 마이클 가들릭
Original Assignee
레이서 제이코버스 코넬리스
더 프록터 앤드 갬블 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 레이서 제이코버스 코넬리스, 더 프록터 앤드 갬블 캄파니 filed Critical 레이서 제이코버스 코넬리스
Publication of KR970701532A publication Critical patent/KR970701532A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424—Polymers characterized by specific structures/properties characterized by the charge anionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 피부 주름 및/또는 피부 위축의 치료가 필요한 포유동물의 피부에 하기 구조를 갖는 안전 유효량의 환상 다가음이온 폴리올 유도체를 포함하는 조성물을 국소적으로 도포하는 것을 포함하는, 포유동물 피부의 피부 주름 및/또는 피부 위축을 조절하는 방법에 관한 것이다 :
상기 식에서, n은 1 내지 3의 정수이고; X는 각각 독립적으로 OSO3 -, OPO3 =, SO3 -, PO3 =, CO2 -및 OH로 구성된 그룹에서 선택되고; 3개 이상의 X는 OH가 아니다.

Description

피부 주름을 조절하기 위한 환상 다가음이온 폴리올 유도체의 사용 방법 (METHODS OF USING CYCLIC POLYANIONIC POLYOL DERIVATIVES FOR REGULATING SKIN WRINKLES)
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. a) 하기 구조를 갖는, 안전 유효량의 환상 다가음이온 폴리올 유도체 :
    (상기 식에서, n은 1 내지 3의 정수이고, X는 각각 독립적으로 OSO3 -, SO3 -, OPO3 =, PO3 =, CO2 -및 OH로 구성된 그룹에서 선택되며; 3개 이상의 X는 OH가 아님); b) 유도체(a)의 전하를 상쇄시키는 양이온; c) 안전 유효량의 일광차단제; 및 d) 연화제를 포함한 국소용 담체를 포함하는 것을 특징으로 하는, 피부 주름을 조절하는데 유용한 국소 도포용 조성물.
  2. 제1항에 있어서, a) 양이온(들)이 H+, Na+, K+, Ca++, Mg++, Al2(OH)5 +, NH4 +, (HOCH2CH2)3NH+, (CH3CH2)3NH|+, HOCH2(CH3)2CNH3 +, (HOCH2)|3CNH3 +, CH3(HOCH2)2CNH3 +, CH3CH2(HOCH2)2CNH3 +, (CH3CH|2)4N+, C16H33(CH3)3N+, (N-C16H33)C5H4N+, 또는 이들의 혼합물 중에서 선택되고; b) X가 각각 독립적으로 OPO3 =, OSO3 -및 OH로 구성된 그룹에서 선택되는 조성물.
  3. 제1항 또는 제2항에 있어서, 폴리올 유도체 0.5% 내지 5%를 포함하는 조성물.
  4. 제1항 내지 제3항 중 어느 한 항에 있어서, 폴리올이 음극 이온삼투요법에 의해 피부에 전달가능한 조성물.
  5. 제1항 내지 제4항 중 어느 한 항에 있어서, X가 OPO3 =또는 OSO3 -인 조성물.
  6. 제1항 내지 제5항 중 어느 한 항에 있어서, a) X가 OPO3 =이고; b) n이 1 또는 2이며; c) 5개 이상의 X가 OH가 아닌 조성물.
  7. 제1항 내지 제6항 중 어느 한 항에 있어서, 1중량% 미만의 C1-을 포함하고, CO3 =은 거의 함유하지 않는 조성물.
  8. 제1항 내지 제7항 중 어느 한 항에 있어서, 폴리올 유도체의 양이 피부에 도포시 0.001㎍/피부㎠ 내지 1000㎍/피부㎠의 농도로 되는 조성물.
  9. 제1항 내지 제8항 중 어느 한 항에 있어서, 무기 인산염, SO4 =또는 무기 인산염과 SO4 =의 혼합물 중 하나 이상을 0.5중량% 이상 포함하는 조성물.
  10. a) 하기 구조를 갖는, 안전 유효량의 환상 다가음이온 폴리올 유도체 :
    (상기 식에서, n은 1 내지 3의 정수이고, X는 각각 독립적으로 OSO3 -, SO3 -, OPO3 =, PO3 =, CO2 -및 OH로 구성된 그룹에서 선택되며; 3개 이상의 X는 OH가 아님); b) 유도체(a)의 전하를 상쇄시키는 양이온; c) 안전 유효량의 일광차단제; 및 d) 연화제를 포함한 국소용 담체를 포함하는 것을 특징으로 하는, 피부 주름을 조절하는데 유용한 제1항 내지 제9항 중 어느 한 항에 따른 국소 도포용 조성물을 제조하기 위한 상기 구성성분들의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960704857A 1994-03-04 1995-03-01 피부 주름을 조절하기 위한 환상 다가음이온 폴리올 유도체의 사용 방법(methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles) KR970701532A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/206,472 US5434144A (en) 1994-03-04 1994-03-04 Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
US08/206,472 1994-03-04
PCT/US1995/002522 WO1995023588A1 (en) 1994-03-04 1995-03-01 Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles

Publications (1)

Publication Number Publication Date
KR970701532A true KR970701532A (ko) 1997-04-12

Family

ID=22766546

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960704857A KR970701532A (ko) 1994-03-04 1995-03-01 피부 주름을 조절하기 위한 환상 다가음이온 폴리올 유도체의 사용 방법(methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles)

Country Status (13)

Country Link
US (1) US5434144A (ko)
EP (1) EP0748210B1 (ko)
JP (1) JP3202239B2 (ko)
KR (1) KR970701532A (ko)
CN (1) CN1082363C (ko)
AT (1) ATE182069T1 (ko)
AU (1) AU1974195A (ko)
CA (1) CA2184479A1 (ko)
CZ (1) CZ257196A3 (ko)
DE (1) DE69510775T2 (ko)
ES (1) ES2133753T3 (ko)
TW (1) TW309428B (ko)
WO (1) WO1995023588A1 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552147A (en) * 1995-04-25 1996-09-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly with alpha hydroxy carboxylic acids
DE19518845A1 (de) * 1995-05-23 1996-11-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure
US5552148A (en) * 1995-06-07 1996-09-03 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Petroleum jelly with inositol phosphates
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US5614511A (en) * 1996-03-11 1997-03-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for treating itchy skin
CA2266496A1 (en) * 1996-09-18 1998-03-26 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
PT1135188E (pt) 1998-11-02 2008-03-19 Alza Corp Dispositivo de electrotransporte incluíndo um agente antimicrobiano compatível
US6221856B1 (en) 1999-02-03 2001-04-24 Inologic, Inc. Inositol derivatives for inhibiting superoxide anion production
US20020192407A1 (en) * 2001-03-01 2002-12-19 The Procter & Gamble Company Pre-moistened wipe with improved feel and softness
US6589922B1 (en) * 2001-03-08 2003-07-08 Dow Pharmaceutical Sciences Skin cleanser comprising a steareth, poloxamer, and a glyceryl monoester
KR100856693B1 (ko) * 2001-04-04 2008-09-04 알자 코포레이션 항미생물제 양립가능성 저장소 조성물을 포함하는 경피전기수송 전달 장치
US20030095990A1 (en) * 2001-06-19 2003-05-22 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Microemulsion facial washes comprising specific oils
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
ITRM20050344A1 (it) * 2005-06-30 2007-01-01 Luca Maria De Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8460687B1 (en) 2009-07-07 2013-06-11 Cosmoceutical Research Center Peeling compositions
CA2780537A1 (en) 2009-11-13 2011-05-19 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device
CN103418077A (zh) * 2013-08-21 2013-12-04 胡宝林 一种治疗手足干裂的护具
JP2023514458A (ja) 2019-06-24 2023-04-05 カステラーナ，ロッサーナ トリクロロ酢酸塩及びヒドロキシ酸を含有する歯科及び皮膚科の使用のための製剤

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3523998A (en) * 1967-10-24 1970-08-11 Gladys Doyle Black Method of wrinkle smoothing
US3806688A (en) * 1972-04-13 1974-04-23 Westinghouse Electric Corp Induction heat cooking apparatus
JPS5617338B2 (ko) * 1972-09-01 1981-04-22
JPS53113030A (en) * 1977-03-09 1978-10-03 Mitsui Toatsu Chem Inc Antitumors containing inositol hexasulfate or its salts as an active constituent
JPS5419942A (en) * 1977-07-12 1979-02-15 Mitsui Toatsu Chem Inc Inositol sulfate aluminum compounds and their preparation
JPS5461153A (en) * 1977-10-25 1979-05-17 Mitsui Toatsu Chem Inc Inositolsulfate ammonium salt and its preparation
JPS54113443A (en) * 1978-02-24 1979-09-05 Mitsui Toatsu Chem Inc Anti-ulcerous agent
US4207339A (en) * 1978-09-07 1980-06-10 Mitsui Toatsu Chemicals, Incorporated Anti-ulcer pharmaceutical composition containing inositol hexasulfate or an alkaline metal salt thereof as active ingredient
DE3535377A1 (de) * 1985-10-03 1987-04-09 Richter Chem Lab Kosmetische mittel
US4937370A (en) * 1987-06-02 1990-06-26 The Procter & Gamble Company Novel chromophores, sunscreen compositions and methods for preventing sunburn
US4999186A (en) * 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
US4952396A (en) * 1986-11-19 1990-08-28 Linus Pauling Institute Of Science & Medicine Method of using phytic acid for inhibiting tumor growth
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
FR2651125B1 (fr) * 1989-08-23 1992-10-02 Roussel Uclaf Compositions pharmaceutiques de type "pates a l'eau".
JP2711597B2 (ja) * 1991-03-20 1998-02-10 ポーラ化成工業株式会社 化粧料
CN1066181A (zh) * 1991-04-30 1992-11-18 武宁县植酸福利厂 疗肤露制造方法
US5268176A (en) * 1991-07-22 1993-12-07 Avon Products, Inc. Method and compositions for the non-invasive treatment of telangiectasia
US5300289A (en) * 1991-12-10 1994-04-05 The Dow Chemical Company Phytate antimicrobial compositions in oral care products
US5340568A (en) * 1992-07-01 1994-08-23 The Procter & Gamble Company Topical composition and method containing deoxy and halo derivatives of lysophosphatidic acids for regulating skin wrinkles

Also Published As

Publication number Publication date
JPH09509934A (ja) 1997-10-07
US5434144A (en) 1995-07-18
MX9603878A (es) 1997-09-30
EP0748210B1 (en) 1999-07-14
CN1082363C (zh) 2002-04-10
ATE182069T1 (de) 1999-07-15
JP3202239B2 (ja) 2001-08-27
CZ257196A3 (en) 1997-01-15
EP0748210A1 (en) 1996-12-18
DE69510775T2 (de) 2000-03-02
CA2184479A1 (en) 1995-09-08
CN1145584A (zh) 1997-03-19
ES2133753T3 (es) 1999-09-16
AU1974195A (en) 1995-09-18
TW309428B (ko) 1997-07-01
DE69510775D1 (de) 1999-08-19
WO1995023588A1 (en) 1995-09-08

Similar Documents

Publication Publication Date Title
KR970701532A (ko) 피부 주름을 조절하기 위한 환상 다가음이온 폴리올 유도체의 사용 방법(methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles)
BR9507917A (pt) Reagente para preparar um agente radiofarmacêutico agente formador de imagem processo para preparar o mesmo kit para preparar uma preparação farmacêutica uso do reagente agente radioterapêutico composição e agente radiofarmacêutico
ES474047A1 (es) Procedimiento para preparar un cebo para moscas sinantropas
DE3479646D1 (en) Crystalline ferroaluminophosphates
BR9300691A (pt) Composicao de xampu para cabelo bem como seu uso
AU7801291A (en) Tinctorial composition based on 5,6-dihydroxyindolines and method for dyeing keratinous fibres
DE69430440D1 (de) Zusammensetzungen zur inhibition von retroviraler verbreitung, die 2',3'-dideoxy-inosin und hydroxyharnstoff enthalten
DE69310602D1 (de) 3',5'-Ditertbutyl-4'-Hydroxyflavone, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung mit Antioxidations- und Antivasokonstriktionsaktivität
ES2105551T3 (es) Utilizacion de derivados de la resorcina substituidos en posicion(es) 4,4 y 5 o 4 y 6 en unas composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
AU7622091A (en) Combination of dihydroxyacetone and monohydroxyindoles for imparting to the skin a coloration similar to a natural tan, multi-compartment device and process for use
GB1411432A (en) Skin treating compositions
AU6444686A (en) Peptic ulcer treatment method
BR9407257A (pt) Composto do tipo bis-naftalimida composição farmacêutica processo para tratamento de um tumor em mamifero uso do composto do tipo bis-naftalimida e processo para a preparação compostos do tipo bis-naftalimida
ES8205756A1 (es) Procedimiento de preparacion de una composicion cosmetica destinada a ser utilizada para el tratamiento de materias queratinicas
BR9711936A (pt) Composição de graxa de urêia, e, engrenagens
ES8105993A1 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
AU4907679A (en) Malignancy treatment by administration of sarcosine, derivatives + mixtures
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
ES472640A1 (es) Procedimiento para preparar seudotrisacaridos
ES2013669A6 (es) Composiciones poliolefinicas para peliculas fotobiodegradables.
AU6483286A (en) Prazosin-pirbuterol combination for bronchoduation
ES8505167A1 (es) Un metodo para la preparacion de 1,8-dihidroxi-10-acil-9-antronas.
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
ES8308470A1 (es) "un procedimiento para la preparacion de una composicion nematocida".

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid